NKG2D-Dependent Activation of Dendritic Epidermal T Cells in Contact Hypersensitivity  by Nielsen, Morten M. et al.
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Morten M. Nielsen1,2, Beatrice Dyring-Andersen1,3, Jonas D. Schmidt1, Deborah Witherden4, Paola Lovato2,
Anders Woetmann1, Niels Ødum1, Steen S. Poulsen5, Wendy L. Havran4, Carsten Geisler1 and
Charlotte M. Bonefeld1
The interaction between keratinocytes (KCs) and skin-resident immune cells has an important role in induction
of contact hypersensitivity. A specific subset of gd T cells termed dendritic epidermal T cells (DETCs) are located in
mouse epidermis, and we have recently shown that DETCs become activated and produce IL-17 in an IL-1b-
dependent manner during contact hypersensitivity. Various receptors on DETCs, including NKG2D, are involved
in DETC responses against tumors and during wound healing. The ligands for NKG2D (NKG2DL) are stress-
induced proteins such as mouse UL16-binding protein-like transcript 1 (Mult-1), histocompatibility 60 (H60), and
retinoic acid early inducible-1 (Rae-1) in mice and major histocompatibility complex (MHC) class I—chain-related
A (MICA), MHC class I—chain-related B, and UL16-binding protein in humans. Here, we show that allergens
upregulate expression of the NKG2DL Mult-1, H60, and Rae-1 in cultured mouse KCs and of MICA in primary
human KCs. We demonstrate that Mult-1 is expressed in mouse skin exposed to allergen. Furthermore, we find
that the vast majority of DETCs in murine epidermis and skin-homing cutaneous lymphocyte-associated antigen
positive gd T cells in humans express NKG2D. Finally, we demonstrate that blocking of NKG2D partially inhibits
allergen-induced DETC activation. These findings demonstrate that NKG2D and NKG2DL are involved in allergen-
induced activation of DETCs and indicate that the NKG2D/NKG2DL pathway might be a potential target for
treatment of contact hypersensitivity.
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INTRODUCTION
Contact hypersensitivity is a T-cell-mediated inflammatory
skin disease induced by exposure of the skin to contact
allergens. Within the last 20 years it has become clear that
keratinocytes (KCs) not only are the main targets for allergen-
specific T cells, but also directly respond to allergens. Thus,
KCs exposed to allergens produce a variety of pro-inflam-
matory cytokines and chemokines (Enk and Katz, 1992;
Cumberbatch et al., 1997 and 2001), and the interactions
between KCs and skin-resident immune cells are central for
initiation of the response to contact allergens (Kaplan et al.,
2012).
A tissue-specific subtype of gd T cells termed dendritic
epidermal T cells (DETCs) is found in mouse epidermis
(MacLeod and Havran, 2011). Arising from fetal precursors
and expressing a canonical Vg3Vd1 TCR (Garman
nomenclature; Garman et al., 1986), DETCs are important
for wound healing, tumor clearance, and tissue homeostasis
(Girardi et al., 2001; Jameson et al., 2002; Jameson et al.,
2004; Sharp et al., 2005). Furthermore, it has been shown that
DETCs have an important role in the response to contact
allergens (Sullivan et al., 1986; Cruz et al., 1989; Welsh and
Kripke, 1990; Huber et al., 1995; Dieli et al., 1997; Dieli
et al., 1998; Girardi et al., 2002; Nielsen et al., 2014).
Interestingly, a previous study showed that allergen-induced
DETC activation was mediated via KCs by a cell–cell contact-
dependent mechanism, and, although DETC activation was
not major histocompatibility complex–dependent, activation
could be partially blocked by treatment with anti-CD3 anti-
bodies (Huber et al., 1995). In accordance, we recently found
that allergens do not directly, but rather indirectly, activate
DETCs by induction of IL-1b production and expression of still
unidentified ligands on KCs (Nielsen et al., 2014).
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DETCs express co-stimulatory receptors such as NKG2D,
JAML, and CD100 (Girardi et al., 2001; Whang et al., 2009;
Witherden et al., 2010; Witherden et al., 2012). Several
NKG2D ligands (NKG2DLs) have been identified in both
humans and mice. In mice, these include retinoic acid early
inducible-1 (Rae-1)a-e, histocompatibility 60 (H60)a-c,
and mouse UL16-binding protein-like transcript 1 (Mult-1;
Malarkannan et al., 1998; Cerwenka et al., 2000;
Carayannopoulos et al., 2002; Whang et al., 2009; Raulet
et al., 2013). In humans, major histocompatibility complex
class I—chain-related A and B (MICA and MICB) and UL-16-
binding proteins have been identified as NKG2DLs (Bauer
et al., 1999). Current evidence indicates that NKG2DLs are
either absent or only weakly expressed by resting cells but
become upregulated as a result of cellular stress, infection, or
tumorigenesis (Raulet et al., 2013). Both Rae-1 and H60 have
critical roles in immune responses against tumors in the skin
and during wound healing (Strid et al., 2008; Yoshida et al.,
2012). However, a role for Mult-1 in skin immunology has not
yet been described.
Evidence of NKG2D-mediated DETC activation was first
provided in a study that found that DETCs can kill carcinoma
cells by an NKG2D-sensitive mechanism (Girardi et al., 2001).
In line with this, recent studies found impaired wound healing
properties of DETCs when NKG2DLs were blocked (Jung
et al., 2012; Yoshida et al., 2012). Whether NKG2D ligation is
sufficient for activation of DETCs by itself or only provides co-
stimulatory signals is still a matter of debate (Nitahara et al.,
2006; Strid et al., 2008). It has been described that KC-specific
upregulation of Rae-1 has the potential to directly activate
DETCs without an apparent need for TCR engagement (Strid
et al., 2008). Whether H60c directly induces DETC activation
is still unclear (Whang et al., 2009; Strid et al., 2011). One
study found that H60c expressed in damaged skin failed to
activate DETCs directly but only provided co-stimulatory
signals (Whang et al., 2009). In contrast, Strid et al showed
that H60c directly induced DETC activation as measured by
induction of IL-13 production (Strid et al., 2011). Thus, it
might be suggested that different NKG2DLs are involved in
regulation of DETC responses by different mechanisms
depending on the type of stimulation received by the skin.
Interestingly, NKG2Dþ natural killer (NK) cells and
NKG2DþCD8þ T cells have been shown to be involved in
the allergic response in patients with nickel allergy and in a
mouse model for palladium allergy, respectively (Carbone
et al., 2010; Kawano et al., 2014). In the mouse model, it was
found that exposure of the skin to palladium increased expres-
sion of H60c in the skin, and that blocking of NKG2D reduced
the allergic response to palladium, indicating that H60c has
an important role in activation of NKG2DþCD8þ T cells
(Kawano et al., 2014). Whether palladium specifically
induced H60c expression on KCs or other cells of the skin
was not determined.
The aim of the present study was to examine whether
allergens induce NKG2DL expression on mouse and human
KCs and to determine the role of NKG2D signaling in contact
hypersensitivity. We found that the experimental allergens
2,4-dinitrobenzenesulfonic acid (DNBS)/DNFB induce rapid
upregulation of the NKG2DL H60, Rae-1, and Mult-1 in the
mouse KC cell line PAM2.12 and of Mult-1 in mouse skin.
Likewise, we found that the common allergen nickel induces
upregulation of MICA in primary human KCs. We found that
DETCs are the only cells expressing NKG2D in mouse
epidermis and that CLAþ skin-homing gd T cells, CD8þ T
cells, and NK cells in humans all express NKG2D. Finally, we
found that anti-NKG2D antibodies block DETC activation
both in vitro and in situ. Thus, our study demonstrates that
NKG2DLs and NKG2D are involved in allergen-induced
interactions between KCs and DETCs, indicating that the
NKG2D/NKG2DL pathway might be a potential target for
treatment of contact hypersensitivity.
RESULTS
DNBS induces upregulation of the NKG2DL Mult-1, Rae-1, and
H60 on PAM2.12 cells
We have recently shown that DETCs have an important role in
the allergic response to contact allergen (Nielsen et al., 2014).
The allergen-induced DETC activation was indirect and
mediated by a combination of IL-1b and activating ligands
expressed on allergen-exposed KCs (Nielsen et al., 2014). As
NKG2DL might activate DETCs independently of TCR
stimulation, we wanted to investigate whether allergens
induce the expression of NKG2DLs on KCs. Consequently,
we stimulated PAM2.12 cells with DNBS and determined the
expression levels of Mult-1, Rae-1, and H60 by flow cytometry
at various time points. DNBS treatment induced upregulation
of all tested NKG2DLs on PAM2.12 cells (Figure 1a and b).
Mult-1 and Rae-1 were both rapidly upregulated as early as 4–
6 hours after DNBS exposure (Figure 1a and b). In contrast,
H60 expression was not upregulated until 24–48 hours of
allergen exposure (Figure 1a and b). Comparable expression
levels were fund on medium-treated cells stained with either
specific NKG2DL antibodies or isotype control (Supplemen-
tary Figure S1 online).
Next, we investigated whether NKG2DLs were expressed in
allergen-exposed skin. Mice were painted with the indicated
concentrations of DNFB in a 1:4 olive oil:acetone (OOA)
mixture or the pure OOA mixture (vehicle) on the dorsal side
of both ears. Twenty-four hours later, the mice were eutha-
nized and proteins were purified from the ears and analyzed
by western blotting using glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) as loading control. Equal amounts of
protein were applied in each sample. As it was seen that
DNFB treatment impaired GAPDH expression, especially in
the high concentration, we made direct comparisons of Mult-1
expression in DNFB-treated ears compared with vehicle-
treated ears. By this analysis, we found a significant 1.5-fold
upregulation of Mult-1 in all DNFB-treated groups when
compared with vehicle-treated mice (Figure 1c and d). We
could not detect Rae-1 and H60 by western blot analysis. To
further investigate the expression of NKG2DLs in allergen-
exposed skin, we made a time-course experiment determining
the expression of NKG2DL mRNA after treatment with 0.05%
DNFB for 6, 12, 24, and 48 hours. We applied this low
concentration of DNFB as the western blot analyses indicated
that this concentration did not affect GAPDH expression,
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which was used as reference in the quantitative reverse
transcriptase in real time (qPCR) experiments. In accordance
with the western blot analyses, the qPCR analyses demon-
strated that Mult-1 mRNA was upregulated after 24 hours but
then became downregulated after 48 hours (Figure 1e). We
could not detect Rae-1 and H60c mRNA by qPCR. To directly
determine whether Mult-1 was expressed in the epidermis
and/or the dermis following exposure of the skin to DNFB, we
exposed mice to 0.05% DNFB for 24 hours. The mice were
subsequently killed and the ears were split into the epidermis
and the dermis. Mult-1 expression was determined separately
in the isolated epidermis and dermis by qPCR. We found that
allergen exposure induced Mult-1 expression in the epidermis
but not in the dermis (Figure 1f).
DETCs are the only cells that express NKG2D in mouse
epidermis
Next, we wanted to determine the subsets of cells in healthy
and allergen-exposed mouse epidermis that express NKG2D.
It has been reported that innate lymphoid cells, natural killer T
cells, CD8þ T cells, and gd T cells can express NKG2D. Mice
were treated with either 0.15% DNFB or vehicle on their ears
for 24 hours and epidermal cell suspensions were subse-
quently prepared and analyzed by flow cytometry. In both
vehicle- and DNFB-treated mice, all NKG2D-expressing cells
were CD3þ (Figure 2a). Of the total NKG2DþCD3þ popula-
tion, DETCs constituted more than 98% of the cells from both
vehicle- and DNFB-treated mice (Figure 2b). These results
demonstrate that DETCs constitute the major NKG2D-expres-
sing cell subset in both healthy and allergen-exposed mouse
epidermis.
Nickel induces upregulation of MICA expression in human
keratinocytes
Although no equivalent to DETCs is found in human skin,
NKG2D-expressing gd T cells are found in both human dermis
and the epidermis (Bos et al., 1990; Ebert et al., 2006).
Therefore, we next investigated the effect of nickel on the
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Figure 1. NKG2D ligands are upregulated following allergen exposure. PAM2.12 cells were treated with vehicle or 0.1% DNBS for the indicated time and the
expression levels of the co-stimulatory ligands Mult-1, Rae-1, and H60 were analyzed by FACS. (a) Histograms of the expression profile of co-stimulatory ligands.
(b) Expression of co-stimulatory molecules as mean flourescent intensity (MFI), MFIDNBS/MFIVehicle at indicated time points. Values are shown as mean±SEM for
three independent experiments. (c) Representative western blots showing Mult-1 and GAPDH expression 24 hours after vehicle or DNFB exposure. (d) Relative
Mult-1 expression of DNFB compared with vehicle-treated ears obtained by semi-quantification of the bands obtained by western blot normalized to the amount of
protein loaded. (e) Expression of Mult-1, Rae-1, and H60 normalized to GAPDH expression as measured by qPCR. (f) Expression of Mult-1 normalized to GAPDH
in the epidermis and the dermis as measured by qPCR. Data are mean±SEM of two experiments. DNBS, 2,4-dinitrobenzenesulfonic acid; GAPDH,
glyceraldehyde-3-phosphate dehydrogenase; H60, histocompatibility 60; Mult-1, mouse UL16-binding protein-like transcript 1; qPCR, quantitative reverse
transcriptase in real time; Rae-1, retinoic acid early inducible-1. *Po0.05, **Po0.01.
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expression of the human NKG2DL MICA and MICB on
primary human KCs. Nickel stimulation induced a 2.5-fold
increase in MICA expression, whereas MICB expression was
unaffected (Figure 3a and b, data not shown). Next, we
determined the expression of NKG2D on skin-homing lym-
phocytes in human peripheral blood from healthy individuals.
Blood samples were collected from seven healthy individuals
and peripheral blood mononuclear cells were purified and
analyzed by FACS. Cutaneous lymphocyte-associated antigen
(CLA) was used as a marker for skin-homing lymphocytes. gd
(CD3þgdþCLAþ ), CD8 (CD3þCD8þCLAþ ), and CD4
(CD3þCD4þCLAþ ) T cells and NK (CD3-CD4-CD8-gd-
CD56high) cells were analyzed for NKG2D expression
(Figure 3c and d). We found that an average of 98% of CLAþ
gd T cells express NKG2D (Figure 3c and d). In addition, 95%
of CLAþ CD8 T cells and 89% of CLAþ NK cells also
expressed NKG2D (Figure 3c and d). In contrast, only 1% of
CLAþ CD4 T cells were found to express NKG2D (Figure 3c
and d). Thus, human gd T cells, CD8þ T cells, and NK cells
with skin-homing potential all express NKG2D and have the
ability to react with NKG2DL.
Blocking NKG2D signaling downregulates allergen-induced
IFN-c production by DETCs
Having observed allergen-induced NKG2DL upregulation on
KCs, we next performed co-culture experiments with allergen
pre-treated PAM2.12 cells and the DETC cell line 7–17.
PAM2.12 cells were pre-treated with various concentrations
of DNBS for 24 hours and the DETC 7–17 cells were
subsequently added. We found that co-culturing of DETC
7–17 cells with PAM2.12 cells induced an allergen-dependent
increase in the number of IFN-gþ DETCs (Figure 4a and b).
Blocking NKG2D signaling with anti-NKG2D antibodies
during the co-culture significantly downregulated the number
of IFN-gþ DETCs (Figure 4a).
Blocking NKG2D in situ partially blocks allergen-induced DETC
activation
As a sign of DETC activation, a change in DETC morphology
from dendritic to round is observed during wound healing and
following allergen exposure (Jameson et al., 2002; Nielsen
et al., 2014). To determine whether NKG2D signaling is
involved in allergen-induced DETC activation in the skin,
we treated ear sheets with either medium, DNBS alone, or
DNBS in combination with blocking anti-NKG2D antibodies
for 24 hours and subsequently studied DETC morphology.
Medium-treated ear sheets mostly contained resting DETCs
(42 dendrites), whereas the majority of DETCs had a round
morphology (zero dendrites) following DNBS treatment
(Figure 5a and b). Interestingly, when blocking anti-NKG2D
antibody was added together with DNBS, rounding up of
DETCs was inhibited and the majority of DETCs still expressed
one to two dendrites (Figure 5a and b). Thus, the allergen-
induced changes in DETC morphology seem partially driven
by NKG2D signaling.
DISCUSSION
In this study, we show that allergens induce expression of
NKG2DLs on KCs from mice and humans, that DETCs
comprise the majority (98%) of cells in the epidermis that
express NKG2D in mice, and that the vast majority of human
skin–homing gd T cells, CD8þ T cells, and NK cells express
NKG2D. Finally, we show that blocking anti-NKG2D anti-
bodies partially inhibits allergen-induced DETC activation as
measured by IFN-g production and DETC rounding.
In normal skin, Mult-1, Rae-1 and H60c are all expressed at
very low levels (Girardi et al., 2001; Nice et al., 2009; Yoshida
et al., 2012). Transcripts encoding Rae-1 and H60c are
upregulated in the skin after 24 hours of treatment with carci-
nogen (Girardi et al., 2001). Furthermore, the expression of
H60c and Rae-1 is upregulated in wounded skin, whereas
Mult-1 is not (Whang et al., 2009; Jung et al., 2012; Yoshida
et al., 2012). In the present study, we found that allergens
induce upregulation of Mult-1, Rae-1, and H60 on PAM2.12
cells in a time-dependent manner. We found that Mult-1
became significantly upregulated in skin treated with DNFB,
whereas we were unable to detect Rae-1 and H60 in both
DNFB- and vehicle-treated skin. Furthermore, we found that
Mult-1 is specifically upregulated in the epidermis and not in
the dermis following allergen exposure. Interestingly, although
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Mult-1 has a role in the defense against tumors and in the
activation of NK cells and macrophages (Diefenbach et al.,
2003), a role for Mult-1 in immune responses in the skin has
not been described previously. In a mouse model of palladium
allergy, it was recently shown that the transcript of H60 is
upregulated in the skin 3 hours after palladium exposure,
whereas Rae-1 transcripts were not upregulated (Kawano
et al., 2014). These differences in NKG2DL expression could
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be explained if different allergens induce expression of
different NKG2DLs or if the expression of the various
NKG2DLs is induced with different kinetics depending on
the dose and potency of the allergen. However, when we
examined the time-course of allergen-induced Mult-1, H60,
and Rae-1 expression, we were only able to detect Mult-1 and
only after 24 hours of treatment. As we used a low
concentration of DNFB in these experiments to avoid
affecting GAPDH expression, we cannot rule out that higher
doses of DNFB might induce Rae-1 and H60. In contrast to
what we observed in the skin, DNBS treatment of PAM2.12
induced expression of all three ligands. This could be due to
increased sensibility to DNBS/DNFB of PAM2.12 compared
with normal KCs or it might indicate that Rae-1 and H60
expression actually are induced in normal KCs by treatment of
the skin with higher concentrations of DNFB. Further investi-
gations are required to solve this question. Whether different
allergens regulate the expression of the NKG2DLs differently
and thereby induce different types of immune response is
unknown. However, just like some contact allergens induce
Th1 responses, whereas others induce Th2 responses (Hayashi
et al., 2001), we find it likely that the induction of various
NKG2DL could be allergen specific.
In accordance with previous studies, we found that essen-
tially all DETCs express NKG2D, suggesting that NKG2D and
its ligands have an important role in DETC activation
(Jamieson et al., 2002; Nitahara et al., 2006). However,
whether DETCs can be activated solely by NKG2D stimula-
tion or whether simultaneous TCR signaling is required for
DETC activation is a matter of debate (Nitahara et al., 2006;
Whang et al., 2009; Yoshida et al., 2012; Ibusuki et al., 2014).
Using recombinant NKG2DLs to elucidate the functional
outcome of NKG2D engagement on DETCs, a recent study
found that all NKG2DL tested triggers DETC degranulation but
not cytokine production in the absence of TCR stimulation
(Ibusuki et al., 2014). The conflicting data may depend on
different cell lines and blocking/activating anti-NKG2D anti-
bodies used in these studies. Indeed, different anti-NKG2D
antibodies have completely different outcomes on DETC
activation, ranging from no activation to induction of both
degranulation and cytokine production in short-term cultured
DETCs (Ibusuki et al., 2014). In the present study, we found
that blocking NKG2D partially inhibited the DNBS-induced
rounding and IFN-g production by DETCs. This indicates that
other factors e.g., TCR ligation and/or cytokines work together
with NKG2D to induce full DETC activation follow-
ing exposure of the skin to allergens. In support of this, we
have recently shown that IL-1b and anti-CD3 antibodies work
synergistically in inducing IL-17A production by DETCs and
that IL-1b enhanced the anti-CD3 antibody-induced IFN-g
production by DETCs (Nielsen et al., 2014). IL-1b is an impor-
tant cytokine in the immune response to contact allergens (Enk
et al., 1993). In our model of contact hypersensitivity, we have
shown that IL-1b is rapidly produced in the skin and that it can
induce partial rounding of DETCs (Nielsen et al., 2014).
However, the interplay between TCR stimulation, cytokines,
and NKG2D ligation in DETC activation and the role of these
in induction of contact allergy needs further investigation.
Several studies have demonstrated that DETCs are required
for normal responses to contact allergens (Dieli et al., 1997;
Dieli et al., 1998). Accordingly, we have recently shown that
lack of gd T cells results in a 50% reduction in allergen-
induced ear swelling, furthermore supporting that other cells,
probably ab T cells, have an important role in the allergen-
induced inflammation (Vocanson et al., 2009; Nielsen et al.,
2014). In addition, others have shown that DETCs might have
an anti-inflammatory role during the response to contact
allergens (Girardi et al., 2002). It could therefore be specu-
lated that blocking NKG2D might not only inhibit the
allergen-induced inflammation mediated by DETCs, but that
it might also block a possible anti-inflammatory effect. The
present study indicates that blocking of NKG2D would reduce
allergen-induced inflammatory responses in situ, but future
in vivo studies are required to finally answer this question.
Although DETCs are not found in human skin, human gd
T cells seem to be involved in immune responses in the skin
80 >2 1–2 0
Over 2 dendrites
1–2 dendrites
0 dendrites
Activation
%
 o
f t
ot
al
 D
ET
C 60
40
20
0
Medium DNBS DNBS + αNKG2D
20 μm
Medium DNBS DNBS +
αNKG2D
Figure 5. Anti-NKG2D partially blocks in situ DETC activation in response to DNBS exposure. Ear sheets were treated with DNBS or DNBSþ anti-NKG2D
antibodies for 24 hours, and DETC morphology was subsequently assessed by confocal microscopy. (a) The insert shows examples of confocal microscopy images
of DETC stained with anti-gdTCR (green). Changes in DETC morphology (42 dendrites ¼ resting; 1–2 dendrites ¼ partially activated; 0 dendrites ¼ activated)
were assessed in a blinded manner. (b) Representative images from each ear-sheet treatment; scale bar is 20mm. A minimum of 200 cells were counted from two
individual experiments with three slides per treatment. Data are presented as mean±SEM. DETC, dendritic epidermal T cell; DNBS, 2,4-dinitrobenzenesulfonic
acid.
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(Toulon et al., 2009; Cai et al., 2011; Laggner et al., 2011;
Dyring-Andersen et al., 2013). Thus, skin-resident gd T cells
are involved in wound healing (Toulon et al., 2009), and
human IL-17-producing gd T cells are involved in the
pathogenesis of psoriasis (Cai et al., 2011; Laggner et al.,
2011). In addition, we have recently shown that gd T cells are
recruited to the skin of patients with nickel allergy following
exposure of their skin to nickel (Dyring-Andersen et al., 2013).
The role of gd T cells in human contact allergy is still not clear,
but our results indicate that it might be pro-inflammatory by
production of IL-17, IL-22, and IFN-g (Dyring-Andersen et al.,
2013). Interestingly, in the present study, we found that nickel
induces upregulation of MICA in primary human KCs.
Furthermore, we found that 98% of CLAþ gd T cells express
NKG2D, suggesting that interactions between NKG2D and
NKG2DL might have an important role in allergen-induced gd
T-cell activation in man as in mice. In addition, both
CLAþCD8þ T cells and CLAþ NK cells express NKG2D
and might also be activated by KC expressing MICA like the gd
T cells (Carbone et al., 2010).
In conclusion, we show that allergens induce upregulation
of NKG2DL on KCs and that NKG2D signaling has a role in
allergen-induced DETC activation. Thus, blocking the inter-
action between NKG2D and NKG2DL might be a potential
target for future treatment of allergic contact dermatitis.
MATERIALS AND METHODS
Mice
Female C57Bl/6 mice were purchased from Taconic (Ry, Denmark).
Mice were housed in specific pathogen-free facilities at the Depart-
ment of Experimental Medicine, Faculty of Health and Medical
Sciences, University of Copenhagen, in accordance with national
animal protection guidelines (license number: 2012-2934-00663).
Cells and culture conditions
The murine KC cell line, PAM2.12, was maintained as previously
described (Nielsen et al., 2014). The 7–17 DETC cell line was
cultured in RPMI 1640 (Sigma-Aldrich, Brndby, Denmark) supple-
mented with 10% FBS and 20 U ml 1 rIL-2. Medium was changed
every other day, and cells were split when they were two-thirds
confluent. Human primary KCs derived from healthy adult skin
(ATCC, Manassa, VA) were cultured in KGM-Gold Medium (Lonza,
Slangerup, Denmark). All cells were maintained at 37 1C, 5% CO2.
After obtaining written informed consent in accordance with the
Helsinki principles for research involving human subjects, peripheral
blood mononuclear cells were purified from blood of seven healthy
individuals using Lymphoprep (Nycomed, Oslo, Norway). The study
was approved by The Committees of Biomedical Research Ethics for
The Capital Region in Denmark (H-4-2011-091)
Materials and reagents
DNFB, DNBS, trypsin from bovine pancreas, phorbol 12-myristate
13-acetate, ionomycin, monensin, and recombinant murine IL-2
(I0523) were purchased from Sigma-Aldrich. Anti-mouse-NKG2D
(C7), anti-mouse-NKG2D (CX5), and fixable viability dye eFluor780
were purchased from eBioscience (San Diego, CA). Anti-human-CD8
(RPA-T8), anti-human-CD4 (OKT4), anti-human-CD3 (OKT3), anti-
human-NKG2D (1D11), and anti-human-CD56 (HCD56) were
purchased from BioLegend (San Diego, CA). Anti-mouse-CD16/CD32
(2.4G2), anti-mouse-gd TCR (GL3), anti-mouse-Vg3 (536), anti-
mouse-CD3e (145-2C11), anti-mouse-IFN-g (XMG1.2), anti-human
gd TCR (B1.1), anti-human/mouse CLA (HECA-452), streptavidin-
APC-Cy7 (554063), Cytofix/Cytoperm (554722), and Perm/Wash
buffer (554723) were all purchased from BD Biosciences (Albertslund,
DK). Anti-mouse-Rae-1 (237104), anti-mouse-H60 (205326), anti-
mouse-Mult-1 (186107), anti-mouse-NKG2D (191004), anti-human-
MICA (159227), anti-human-MICB (236511), and mouse IgG2B
isotype control (133303) were purchased from R&D Systems
(Abingdon, UK). StemPro Accutase (A11105-01) was purchased from
Life Technologies (Nærum, Denmark).
Sensitization protocol
Mice were painted with 25ml of DNFB in a 1:4 OOA mixture on the
dorsal side of both ears. The concentrations of DNFB (0.05%, 0.15%
and 0.5%) used are indicated in the respective experiments. Vehicle-
treated mice were painted with OOA. Twenty-four hours later, mice
were killed and ears were collected for protein purification and
subsequent western blotting or FACS analysis.
Flow cytometry
Epidermal single cell suspensions from ears of C57Bl/6 mice were
obtained as previously described (Nielsen et al., 2014). For FACS
analysis of epidermal cell suspensions, PAM2.12 cells, co-culture
cells, and peripheral blood mononuclear cells were stained and
analyzed as previously described (Dyring-Andersen et al., 2013;
Nielsen et al., 2014).
Western blot
Biopsies from ears treated either with various concentrations of DNFB
or vehicle for 24 hours were homogenized individually and lysed
simultaneously using Precellys technology from Bertin Technologies
(Montigny-le-Bretonneux, France). Homogenized ear tissue samples
were adjusted to 50mg protein using Bradford assay and subjected to
SDS-PAGE using pre-casted 10% Bis-Tris acrylamide gel (BioRad,
Copenhagen, Denmark). Proteins were then blotted to a PVDF
membrane by wet transfer and probed for Mult-1, Rae-1, H60, and
GAPDH (R&D Systems, Abingdon, UK). Relative Mult-1 expression of
treated mice was calculated based on semi-quantification of the Mult-
1 bands obtained by western blotting relative to the control samples
from mice treated with vehicle and normalized to the amount of
loaded protein.
RNA purification and qPCR analysis
Mice were painted with 25ml of 0.05% DNFB in OOA for the
indicated time. In some experiments, the ears were split into the
epidermis and the dermis as previously described (Nielsen et al.,
2014). RNA was purified and qPCR analyses were performed
as previously described (Bonefeld et al., 2014). The following
primers were used: Rae-1 (Mm00558293_g1), UL-16-binding
protein (Mn01180648_m1), H60c (Mn0424326_m1), and GAPDH
(Pre-Developed TaqMan Assay Reagents, Mouse GAPDH (20 )
#4352932E; Life Technologies).
KC stimulation assay
PAM2.12 cells were plated at 2.5 105 cells per well in 6-well plates
and incubated overnight at 37 1C. The following day cells were
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stimulated with DNBS for the indicated time and cells were harvested
using StemPro Accutase and stained as described above. Primary
human KCs were incubated for 24 hours in the absence of hydro-
cortisone cells and subsequently stimulated with 10mg ml 1 nickel
chloride for 24 hours or medium control. Cells were loosened with
trypsin, stained with antibodies to MICA and MICB, and analyzed by
flow cytometry.
PAM2.12/DETC co-culture assay
DNBS was added at indicated concentrations to 3 104 of PAM2.12
cells in 96-well plates and incubated for 24 hours. The cells were
subsequently washed to remove DNBS. 1 105 of 7–17 cells were
seeded on the PAM2.12 cells and co-incubated for 4 hours. In some
experiments, DETCs were pre-incubated for 15 minutes with
50mg ml 1 anti-NKG2D (191004) antibodies as indicated.
Stimulation and preparation of ear sheets
Ear sheets were prepared by separating the dorsal and ventral sides of
naive C57Bl/6 ears. Subsequently, ear pieces were floated dermis-side
down for 24 hours at 37 1C in DMEM medium alone or in DMEM
medium containing either 0.1% DNBS or 0.1% DNBS plus
40mg ml 1 anti-NKG2D (C7). The epidermal sheets were subse-
quently prepared for immunohistology as previously described
(Nielsen et al., 2014). A minimum of 200 cells per slide were
counted from two individual experiments with three slides per
treatment.
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